S6K1-IN-DG2

CAS No. 871340-88-4

S6K1-IN-DG2( —— )

Catalog No. M34405 CAS No. 871340-88-4

S6K1-IN-DG2(S6K1InhibitorDG2) is a potent p70S6K inhibitor with an IC50 value of less than 100 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 85 In Stock
10MG 132 In Stock
25MG 264 In Stock
50MG 389 In Stock
100MG 553 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    S6K1-IN-DG2
  • Note
    Research use only, not for human use.
  • Brief Description
    S6K1-IN-DG2(S6K1InhibitorDG2) is a potent p70S6K inhibitor with an IC50 value of less than 100 nM.
  • Description
    S6K1-IN-DG2 (Compound 66) is a p70S6K inhibitor (IC50: < 100 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    mTOR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    871340-88-4
  • Formula Weight
    389.25
  • Molecular Formula
    C16H17BrN6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (128.45 mM; Ultrasonic )
  • SMILES
    BrC=1C2=C(N=CN=C2NN1)N3CCN(CC3)C4=C(OC)C=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Neel K. Anand, et al. Kinase modulators and methods of use. Patent. WO2005117909.
molnova catalog
related products
  • P-2281

    P-2281 is an mTOR inhibitor with anticancer and anti-inflammatory properties.P-2281 inhibits dextran sulfate sodium (DSS)-induced colitis by suppressing T-cell function and is effective in a mouse model of human colitis.

  • CZC-25146

    CZC-25146 is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively.

  • Sapanisertib

    Sapanisertib (INK-128, MLN0128) is a potent, ATP-competitive, orally active dual mTORC1/2 inhibitor with Ki of 1.4 nM in cell-free assays.